SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — History and Physical — Audre Lorde — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.
| Patient | Audre Lorde |
|---|
| Date of birth | 1934-02-18 |
|---|
| Identifiers | MRN HR-ML016-SYN-TD; SSN (made up) 000-16-2937 |
|---|
| Document date | 1979-03-09 |
|---|
| Author | Naomi Fairweather, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Visit
Primary care survivorship visit five and a half months after right mastectomy for stage IA breast cancer, on tamoxifen [S]
History of Present Illness
This fictional modern episode addresses the presenting concerns below. [S]
- Moving her breast cancer survivorship care to primary care, with the oncology team kept informed; mild hot flashes on tamoxifen. [S]
- Wants complete information and to make her own decisions. She chose a flat closure without reconstruction and does not wish to wear an external prosthesis; she asks that this not be raised again unless she raises it. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- Audre Lorde was born Audrey Geraldine Lorde on February 18, 1934, in New York City; her parents were immigrants from Grenada. [D]
- Lorde was a poet, essayist, and novelist. In her poetry and prose she wrote about matters important to her as a woman of color, as a lesbian, as a mother, and as a feminist; a reference biography describes her as an African American lesbian feminist and poet. [D]
- In 1977 a doctor found a tumor in Lorde's breast that, after about three weeks of uncertainty, proved benign. In a talk given that year to the Modern Language Association she said: "Your silence will not protect you." [D]
- On Labor Day 1978, during a routine self-examination, Lorde found a lump in her right breast; a diagnosis of malignancy and a mastectomy followed. She described the experience in The Cancer Journals. [D]
- After her mastectomy Lorde chose never to hide the fact of her missing breast. She refused to wear the "wad of lambswool pressed into a pale pink breast-shaped pad" pushed on her by nurses and medical counselors, and she was repeatedly scolded for posing a threat to cancer patient "morale." [D]
4 later historical claims are omitted because they describe events after the index age. See the teaching note.
Past Medical History
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|
| 1977 | Breast tumor found by a doctor, benign after about three weeks of uncertainty | D (CLM-0003) |
| 1978 | Lump in the right breast found at self-examination on Labor Day, followed by a diagnosis of breast cancer and a mastectomy; she declined a breast prosthesis | D (CLM-0004, CLM-0005) |
Family History
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
Social History
- Occupation: poet and essayist; writes most days and gives readings [S]
- Never smoker; alcohol rarely; walks most days; cooks most meals at home with plenty of vegetables and whole grains [S]
- Lives with her partner and her two teenage children; independent [S]
- Supports: her family and a wide circle of writers and friends [S]
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Tamoxifen 20 mg oral tablet, one tablet by mouth once daily, planned for at least five years | One tablet once daily | Oral route | 1978-10-27 | active | S |
Review of Systems
Positive for the concerns in the history of present illness. Alert, articulate, and direct; asks for complete information and makes her own decisions about her care. Mood euthymic; PHQ-9 and GAD-7 in the minimal range. No other systems reported as affected in this synthetic episode. [S]
General Status
Alert and engaged. Independent in all activities of daily living; full range of motion of the right shoulder; writing and walking daily. [S]
Physical Exam
Vital signs recorded on 1979-03-09; see the Vital Signs section. Mental status: Alert, articulate, and direct; asks for complete information and makes her own decisions about her care; Mood euthymic; PHQ-9 and GAD-7 in the minimal range. The physical examination is limited to the findings relevant to this synthetic episode. [S]
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 1979-03-09 | Body height | 168 | cm | S |
| 1979-03-09 | Body weight | 72 | kg | S |
| 1979-03-09 | Body mass index (BMI) [Ratio] | 25.5 | kg/m2 | S |
| 1979-03-09 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1979-03-09 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1979-03-09 | Heart rate | 74 | /min | S |
| 1979-03-09 | Respiratory rate | 14 | /min | S |
| 1979-03-09 | Body temperature | 36.7 | Cel | S |
| 1979-03-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 1979-03-09 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | | | S |
| 1979-03-09 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 3 | {score} | | | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Invasive ductal carcinoma of the upper outer quadrant of the right breast, stage IA (pT1c pN0(sn) M0), grade 2, estrogen and progesterone receptor positive, HER2 negative, recurrence score 14; treated by right total mastectomy with sentinel node biopsy and on adjuvant tamoxifen; synthetic modern counterpart of the documented 1931 breast cancer and mastectomy | active | confirmed |
C50.411 | S — Synthetic tumor details and treatment; the diagnosis and the mastectomy are documented (D), but no tumor details from her lifetime are used. |
| Estrogen receptor positive status of the breast cancer (ER 90 percent, PR 60 percent) | active | confirmed |
Z17.0 | S — Synthetic receptor result; no receptor status from her lifetime is known. |
| Absence of the right breast after mastectomy with flat closure; she chose not to have reconstruction and not to wear an external prosthesis | active | confirmed |
Z90.11 | S — Synthetic coding of the documented mastectomy; the decision about a prosthesis echoes her documented choice and is respected as her own. |
| Long-term use of tamoxifen as adjuvant endocrine therapy | active | confirmed |
Z79.810 | S — Synthetic treatment status. |
Assessment
- Invasive ductal carcinoma of the upper outer quadrant of the right breast, stage IA (pT1c pN0(sn) M0), grade 2, estrogen and progesterone receptor positive, HER2 negative, recurrence score 14; treated by right total mastectomy with sentinel node biopsy and on adjuvant tamoxifen; synthetic modern counterpart of the documented 1931 breast cancer and mastectomy: active, confirmed [S]
- Estrogen receptor positive status of the breast cancer (ER 90 percent, PR 60 percent): active, confirmed [S]
- Absence of the right breast after mastectomy with flat closure; she chose not to have reconstruction and not to wear an external prosthesis: active, confirmed [S]
- Long-term use of tamoxifen as adjuvant endocrine therapy: active, confirmed [S]
Plan of Treatment
- Medical oncology consultation to confirm the adjuvant endocrine therapy plan, advise on hot flashes, set the surveillance plan, and advise on genetic assessment. Guideline: NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 5.2025 (2025); Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update (2019) [S]
- Tamoxifen 20 mg daily for at least five years, with questions at every visit about hot flashes, abnormal vaginal bleeding, and leg swelling or breathlessness, and a yearly gynecologic assessment. Guideline: Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update (2019); CMID: Clinical Monitoring Intelligence Database, breast cancer monograph (2026) [S]
- Lymphedema risk counseling and arm checks at every visit; bone health by calcium and vitamin D from diet and weight-bearing exercise; distress, depression, and anxiety screening at intervals. Guideline: American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin 2016;66(1):43-73 (2016); CMID: Clinical Monitoring Intelligence Database, breast cancer monograph (2026) [S]
- Written survivorship care plan, at least 150 minutes of activity a week, alcohol at or below one drink a day, and her decisions about reconstruction and a prosthesis recorded and respected. Guideline: American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin 2016;66(1):43-73 (2016); CMID: Clinical Monitoring Intelligence Database, breast cancer monograph (2026) [S]
- Referral to medical oncology, Beatriz Lozano, MD, ordered 1979-03-09 [S]